Group One Trading’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-300
Closed -$4.89K 8793
2025
Q4
$4.89K Sell
300
-900
-75% -$13.6K ﹤0.01% 7192
2025
Q3
$14K Sell
1,200
-7,800
-87% -$102K ﹤0.01% 6957
2025
Q2
$104K Buy
9,000
+800
+10% +$7.29K ﹤0.01% 4924
2025
Q1
$71.6K Buy
8,200
+5,800
+242% +$73.1K ﹤0.01% 4873
2024
Q4
$34.5K Buy
2,400
+200
+9% +$3.16K ﹤0.01% 5338
2024
Q3
$49.7K Sell
2,200
-9,700
-82% -$201K ﹤0.01% 4654
2024
Q2
$231K Sell
11,900
-21,000
-64% -$550K ﹤0.01% 3267
2024
Q1
$1.23M Buy
32,900
+32,800
+32,800% +$1.44M ﹤0.01% 1898
2023
Q4
$5.6K Sell
100
-6,400
-98% -$278K ﹤0.01% 6461
2023
Q3
$268K Sell
6,500
-100
-2% -$5.2K ﹤0.01% 3548
2023
Q2
$369K Buy
6,600
+5,800
+725% +$314K ﹤0.01% 3336
2023
Q1
$44.6K Buy
+800
New +$37.4K ﹤0.01% 4940
2022
Q4
Sell
-8,200
Closed -$234K 8117
2022
Q3
$234K Hold
8,200
﹤0.01% 3982
2022
Q2
$371K Buy
+8,200
New +$425K ﹤0.01% 3693
2021
Q4
Sell
-1,500
Closed -$218K 8865
2021
Q3
$218K Sell
1,500
-700
-32% -$120K ﹤0.01% 5082
2021
Q2
$431K Sell
2,200
-7,400
-77% -$1.34M ﹤0.01% 4378
2021
Q1
$1.74M Sell
9,600
-12,200
-56% -$2.11M ﹤0.01% 2626
2020
Q4
$3.09M Buy
21,800
+14,700
+207% +$2.13M 0.01% 1675
2020
Q3
$885K Sell
7,100
-2,300
-24% -$241K ﹤0.01% 2318
2020
Q2
$840K Hold
9,400
﹤0.01% 2194
2020
Q1
$586K Buy
+9,400
New +$734K ﹤0.01% 1940

Other funds holding TXG

Group One Trading's TXG Position: Q1 2026 in Review

Group One Trading opened a new position in 10x Genomics (TXG) in Q1 2026: 3,843 shares worth $81.6K. The stake represents ﹤0.01% of the portfolio and ranks #4907 among its holdings. This is a return to the name: Group One Trading previously reported a position in TXG as recently as Q2 2025.

Group One Trading first reported a position in TXG in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.31M in Q1 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Group One Trading held 3,843 shares of 10x Genomics worth $81.6K as of Q1 2026.
  • 10x Genomics was a new Group One Trading position in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4907 holding.
  • Group One Trading first reported a position in 10x Genomics in Q4 2019 and has held it in 11 quarters since.
  • Group One Trading's 10x Genomics position peaked at $1.31M in Q1 2024.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.